Clinical trials
Phase 3 Hypertension, Pulmonary trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 19 |
| Recruiting | 5 |
| Withdrawn | 3 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Unknown status | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| United Therapeutics | 14 |
| Bayer | 5 |
| Gilead Sciences | 4 |
| Eli Lilly and Company | 3 |
| NICHD Neonatal Research Network | 3 |
| Pfizer | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 |
| Actelion | 2 |
| Biogen | 2 |
| Insmed Incorporated | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 62 |
| Pulmonary Arterial Hypertension | 24 |
| Heart Failure | 6 |
| Hypertension | 6 |
| Familial Primary Pulmonary Hypertension | 5 |
| Lung Diseases, Interstitial | 5 |
| Vascular Diseases | 5 |
| Cardiovascular Diseases | 4 |
| Lung Diseases | 4 |
| Respiratory Tract Diseases | 4 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.